Inmode Ltd. Stock Price, News & Analysis

InMode Ltd. (NASDAQ: INMD) reported Q1 2022 revenues of $85.9 million, a 31% year-over-year increase. GAAP net income was $31 million, reflecting a 16% rise from the prior year, achieving GAAP diluted EPS of $0.36. The company noted record consumable revenues of $14 million, up 79% year-over-year. Despite facing global supply chain challenges affecting gross margins, management reiterated a full-year revenue guidance of $415-$425 million and robust long-term gross margin targets of 84%-86%.

InMode Ltd (Nasdaq: INMD) announced its expected financial results for Q1 2022, projecting revenue between $85.0 million and $85.5 million and non-GAAP earnings per diluted share between $0.38 and $0.39. The company noted an 83% to 84% gross margin, reflecting growth in demand for its minimally invasive solutions. Despite challenges from COVID-19 variants and supply chain issues, InMode managed to maintain productivity and meet delivery expectations. A conference call is scheduled for May 2, 2022, to discuss the results further.

InMode Ltd. (Nasdaq: INMD), a leading provider of innovative medical technologies, will participate in a virtual fireside chat at the 21st Annual Needham Healthcare Conference on April 14, 2022, at 4:30 p.m. ET. The event will feature CEO Moshe Mizrahy, CFO Yair Malca, and CMO Dr. Spero Theodorou, hosted by CFA Mike Matson. Management will also hold one-on-one meetings that day. A live link for the chat is available here, with more info on InMode's investor relations site.

InMode Ltd. (Nasdaq: INMD) announced a new share repurchase program, approving the buyback of up to 1 million ordinary shares. This decision follows the successful completion of a previous buyback in September 2020, reflecting the company's confidence in its long-term outlook. The program, funded by available cash, aims to enhance shareholder value and follows a trend of fiscally responsible investments. The board emphasized strong cash flow and a robust balance sheet as key factors justifying the buyback.

InMode Ltd. (Nasdaq: INMD) announced participation in two investor conferences in March 2022. The company will host a virtual fireside chat at the Oppenheimer 32nd Annual Healthcare Conference on March 15, at 10:40 a.m. EST. Additionally, InMode will present in-person at the Barclays Global Healthcare Conference on March 17, at 9:00 a.m. EST, located at the Loews Miami Beach Hotel. These events provide opportunities for one-on-one meetings with investors. For further details, visit InMode's website.

InMode Ltd. (Nasdaq: INMD) reported strong financial results for Q4 and FY 2021, with quarterly revenues reaching a record $110.5 million, a 47% increase year-over-year. The company achieved a GAAP net income of $52.7 million for Q4, and $165 million for the full year, compared to $75 million in 2020. Full year revenues totaled $357.6 million, a 73% increase. The company expects revenues for 2022 in the range of $415-$425 million with non-GAAP earnings per diluted share between $2.06 and $2.11. InMode continues to expand internationally and maintain healthy gross margins of 85%.

InMode Ltd. (Nasdaq: INMD) announced its anticipated financial results for the fourth quarter and full year 2021, revealing record revenues. The company expects fourth quarter revenue between $109.5M and $110M, and full year revenue of $356.5M to $357M, surpassing earlier guidance of $343M to $347M. Non-GAAP earnings per diluted share are forecasted at $0.61 for Q4 and $2.02 to $2.03 for the full year. Looking ahead, InMode projects 2022 revenues between $415M and $425M.

InMode Ltd. (Nasdaq: INMD), a global leader in innovative medical technologies, will present at the 24th Annual Needham Virtual Growth Conference on January 12, 2022, at 9:15 am EST. CEO Moshe Mizrahy and CFO Yair Malca will lead the presentation, which will be webcast live and archived for 90 days. Management will also offer one-on-one virtual meetings during the event. InMode specializes in minimally invasive radio-frequency technologies for various medical fields, including plastic surgery and dermatology.

InMode Ltd. (Nasdaq: INMD) announced participation in three virtual investor conferences. CEO Moshe Mizrahy and CFO Yair Malca will present at the Stifel 2021 Healthcare Conference on November 16 at 9:20 PM EST, the Hidden Gem Conference on November 17 at 11:15 AM EST, and the Canaccord Virtual MedTech Forum on November 18 at 1:30 PM EST. Webcasts will be available for the Stifel and Canaccord events. Investors can schedule one-on-one virtual meetings during these conferences.